+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Search Bar & Filters

Found 4 Actively Recruiting clinical trials

C

Actively Recruiting

Researchers are studying the best behavioral treatment for insomnia in active duty service members who have both insomnia and prolonged postconcussive symptoms lasting at least three months after a mild traumatic brain injury mTBI. This study compares Cognitive Behavioral Therapy for Insomnia CBT-I with Brief Behavioral Therapy for Insomnia BBT-I to see how each affects insomnia severity and related postconcussive symptoms. The research also investigates the impact on blood-based biomarkers to better understand treatment effects. Participants will receive either six weekly 50-minute sessions of CBT-I or four weekly 30-minute sessions of BBT-I, both delivered individually by trained behavioral health providers. Treatments can be given in person or through telehealth to fit participants schedules. Completion requires attending at least four CBT-I sessions or three BBT-I sessions, along with baseline, 7-week, and 12-week follow-up assessments. During the study, participants will undergo evaluations that include the Insomnia Severity Index, Neurobehavioral Symptom Inventory, and NIH Toolbox assessments at baseline and follow-ups. Additional questionnaires will assess sleep beliefs, nightmares, sleepiness, mood, fatigue, headache impact, anxiety, and suicidality. The study lasts about 12 weeks, with monitoring to track changes in symptoms and treatment effects.

Age: 18Years - 45YearsAll GendersPhase Not Applicable
1 location
M

Actively Recruiting

Researchers are studying Medicare beneficiaries with Lumbar Spinal Stenosis LSS and Neurogenic Claudication NC to compare outcomes after two different procedures MILD Percutaneous Image-Guided Lumbar Decompression and Interspinous Process Decompression IPD. This observational study tracks patients treated since January 1, 2017, evaluating the rates of surgical and minimally invasive interventions as well as any harms related to these procedures over 24 months. The study uses Medicare claims data and does not require prior patient consent or IRB oversight. The study includes two groups of patients those who received the MILD procedure, involving partial decompression under image guidance by removing tissue and bone at the affected spinal level, and those who underwent IPD, a device-based decompression technique. Both groups are observed through Medicare data for two years after their initial procedure to assess the need for further surgeries or interventions and to monitor for any complications. Participants are followed for 24 months after their index procedure using Medicare claims data. Researchers monitor the rates of harms associated with the initial treatment and the frequency of additional surgical or minimally invasive interventions. Since this is an observational study, data collection relies on existing Medicare records without direct patient involvement, and the study will continue enrolling patients until the sponsor stops it.

Age: 18Years +All Genders
2393 locations
S

Actively Recruiting

Researchers are studying rehabilitation programs for individuals with Achilles tendon pain, aiming to find effective treatments that improve pain and reduce disability. This trial focuses on expanding access to care for military personnel, especially those in battlefield settings or busy military facilities, by comparing different approaches to physical therapy. The study also seeks to identify early signs that predict how well someone will respond to rehabilitation. Participants will be randomly assigned to one of two rehabilitation programs a single-visit, physical therapist-initiated program delivered via telehealth with self-paced online modules, or a multi-visit, physical therapist-guided program with six telehealth sessions. Both programs include education about Achilles tendinopathy and a progressive exercise plan, with participants completing home exercise logs and quizzes. The study lasts 8 weeks, but outcomes will be assessed up to one year. During the trial, participants will complete online modules or telehealth visits that include exercise instruction and education. Researchers will evaluate tendon pain and disability at 4 weeks as primary outcomes, with additional assessments at 8 weeks, 26 weeks, and 1 year. The study also collects baseline data and early responses at 2 weeks to help predict treatment success. This helps monitor progress and safety throughout the study period.

Age: 18Years - 60YearsAll GendersPhase Not Applicable
2 locations
P

Actively Recruiting

Healthy Volunteer

Researchers are evaluating a new treatment designed to address anger and aggression stemming from military-related betrayal among active duty military service members and veterans aged 18 and older. This study aims to determine whether participants find the treatment satisfactory and if it is practical to deliver in a military outpatient setting. The study will compare groups with different wait times before treatment to explore how timing affects outcomes. Participants will be randomly assigned to one of three groups with wait times of 2, 3, or 4 weeks before starting the treatment. The treatment, called Countering Chronic Anger and Aggression Related to Trauma and Transgressions CART, involves 14 therapy modules delivered twice a week. Sessions are conducted face-to-face at the STRONG STAR offices or through secure telebehavioral health methods when necessary. During the wait period, participants complete brief assessments twice weekly and have weekly check-in calls with their therapist. During treatment, participants continue regular assessments before each session to measure anger, aggression, and social interactions. After treatment, they complete follow-up surveys and interviews about a month later. The study measures outcomes including satisfaction with the treatment, levels of anger and aggression, interpersonal problems, and psychosocial functioning. Participation may last from the initial wait period through about 18 weeks after starting the study.

Age: 18Years +All GendersPhase Not Applicable
1 location